SBIR/STTR Research Award

AS A FUNCTION OF ETHYLENE OXIDE STERILIZATION AND STORAGE TIME.

Award identifier f17a25b48ec54d0c3325f235ff45a9d31cb6d99db4cf586874ad4bdb034b333fAwarding agency Department of Health and Human Services

Award amount

$50,000

Program and phase

SBIR · Phase I

Award year

1985

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
BOSTON BIOTECHNOLOGY CORPORATION
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

AS A FUNCTION OF ETHYLENE OXIDE STERILIZATION AND STORAGE TIME.PRIMARY BILIARY CIRRHOSIS (PBC) IS A DEGENERATIVE LIVER DISEASE OF UNKNOWN ETIOLOGY WHICH FREQUENTLY RESULTS IN DEATH WITHIN 5 TO 10 YEARS OF THE ONSET OF SYMPTOMS. LABORATORY DIAGNOSIS OF PBC IS CURRENTLY BASED UPON HISTOLOGICAL FINDINGS IN BIOPSY MATERIAL AND DETECTION OF SERUM ANTIMITOCHONDRIAL ANTIBODIES (AMA) BY IMMUNOFLUORESCENT STAINING OF UNFIXED TISSUE. AS CURRENTLY PERFORMED, NEITHER PROCEDURE CAN RELIABLY DIFFERENTIATE PBC FROM CHRONIC ACTIVE HEPATITIS OR OTHER AUTOIMMUNE DISORDERS. SINCE AMA ARE PRESENT IN 99% OF PBC SERA AND IN A VERY SMALL PERCENTAGE OF THE GENERAL POPULATION, THE USE OF AMA AS A DIAGNOSTIC CRITERION IS WARRANTED PROVIDED THAT APPROPRIATE LABORATORY TECHNIQUES ARE AVAILABLE. THEREFORE, IT IS PROPOSED THAT AN IMPROVED METHODOLOGY BE DEVELOPED FOR THE DETECTION OF SPECIFIC AMA WHICH ARE PRESENT IN PBC SERA BUT NOT IN CHRONIC LIVER DISEASES OR AUTOIMMUNE DISORDERS. PRELIMINARY RESULTS HAVE IDENTIFIED A MITOCHONDRIAL ANTIGEN WHICH REACTS WITH 90% OF THE PBC SERA TESTED BY IMMUNO BLOT TRANSFER. CROSS-REACTIVITY WITH OTHER CHRONIC LIVER DISEASES WAS LESS THAN 10% UNDER APPROPRIATE ASSAY CONDITIONS. FURTHER PURIFICATION OF THE PBC-SPECIFIC ANTIGEN AND OPTIMIZATION OF THE IMMUNOASSAY PROCEDURES SHOULD PROVIDE A RELIABLE DIAGNOSTIC TECHNIQUE FOR PBC WHICH CAN BE MADE AVAILABLE TO THE

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.